Ibuprofen Prices

Ibuprofen Prices September 2024

The ibuprofen prices in the United States for Q3 2024 reached 10,700 USD/MT in September. Prices experienced significant variability, marked by strong demand alongside limited inventories. Toward the closing of the quarter, prices rose marginally in comparison to Q2, with a notable spike during the second part of Q3. This pattern highlights the resilience and adaptability of the market concerning external challenges.

The price trend for ibuprofen in China for Q3 2024 settled at 22,100 USD/MT in September. The country exhibited notable price volatility due to stronger industrial productivity, high overseas requirements, and ongoing interruptions in supply networks. Q3 witnessed a notable rise in prices during the second half as compared to the first, maintaining market momentum regardless of a marginal decrease compared to Q2. This pattern highlights the durability of the ibuprofen industry amid continuous difficulties.

In Germany, the ibuprofen prices for Q3 2024 reached 10,470 USD/MT in September. The country experienced significant shifts in prices, following a persistent ascending trend and exhibiting notable improvement compared to Q2. Prices climbed continually throughout the quarter, highlighting an optimistic environment in Germany.

Ibuprofen Prices June 2024

The ibuprofen prices in the United States for Q2 2024 reached 22,800 USD/MT in June. The country experienced significant price shifts driven by strong demand from end-use industries and proactive mass purchasing by distributors to mitigate challenges in the future. Seasonal elements, including the premature onset of the peak transportation period, further contributed to the price increase. This trend highlights the resilience of the market in the face of continual issues and reflects pragmatic responses by market participants, signaling a strong and steadily improving upward trajectory in prices.

The price trend for ibuprofen in China for Q2 2024 settled at 10,650 USD/MT in June. The country experienced significant fluctuations in prices due to heightened export activity and rising interest from both domestic and international clients.  Seasonal influences further contributed as industry players utilized this favorable environment toward the end of Q2. This rise in prices indicates an optimistic market sentiment driven by inventory limitations, economic influences, and the judicious adapting of prices by distributors.

In Germany, the ibuprofen prices for Q2 2024 reached 10,450 USD/MT in June. The country witnessed significant price volatility. The market exhibited a continuous upward trend due to strong requirements from end-use industries, severe inventory shortages, and pressures from inflation. Procurement activities notably increased in the second half of Q2, leading to a marked rise in prices in comparison to the former part. Toward the close of the quarter, ibuprofen prices reflected a positive trend, highlighting an optimistic industry outlook.

Ibuprofen Prices December 2023

In the last quarter of 2023, there was an average decrease in ibuprofen prices in the United States. Stock prices dropped as a result of investors being wary due to growing inflation and possible recession fears. In addition, there was an excess of the commodity available due to an imbalance in supply and demand. In the end, Q4FY2023 saw ibuprofen prices in the USA hit 9510 USD/MT.

Throughout the last quarter of 2023, the average cost of ibuprofen decreased in China. The nation's market was oversupplied with goods, which forced producers to reduce their profit margins in order to clear off their inventory. The price of ibuprofen in China ended the quarter at 21515 USD/MT.

During Q4FY2023, Germany showed indications of an economic slowdown, which had an adverse effect on ibuprofen prices. Due to poor product demand, a delay in manufacturing, and large currency changes, prices fell in the first few months of Q4. By December, there was a discernible rise in ibuprofen prices as a result of more people purchasing the medication. At the end of the fourth quarter, prices were 9870 USD/MT overall.

Regional Coverage

The report provides a detailed analysis of the ibuprofen market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the ibuprofen price trend.

Global Ibuprofen Price

The report offers a holistic view of the global ibuprofen pricing trends in the form of ibuprofen price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of ibuprofen but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed ibuprofen demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Ibuprofen Price

Q3 2024:

In the third quarter of 2024, ibuprofen prices in Europe witnessed a major price increase driven by several circumstances that impacted industry conditions. Rising manufacturing expenses in major production hubs, driven by higher feedstock and operational expenses, were a primary influence. This was further heightened by a notable rise in international requirements as various sectors boosted production to meet rising consumer needs. Supply network interruptions also influenced prices, with shortages caused by facility closures at vital manufacturing sites limiting supply and intensifying the pressure on prices. Additionally, currency fluctuations increased the costs of import, further influencing the upward pricing trend.

Q2 2024:

Throughout the second quarter of 2024, ibuprofen prices in Europe experienced a significant rise, driven mainly by increased manufacturing expenses and drastic interruptions in supply networks. Several factors contributed to this increase, including higher energy and raw material expenses and rising shipping costs, driven by international operational challenges. Environmental issues added to these supply network difficulties, creating bottlenecks. International challenges, such as the closure of major production facilities in Asia, added to the pressure on supply networks, prompting local participants to increase prices in order to control supply shortages and utilize trade openings. This trend of ongoing hikes in price and inventory constraints reflects a positive market environment.

Q4 2023:

The prices of ibuprofen in the European region declined during the final quarter of 2023. The initial two months of Q4 experienced a decline in demand and abundant product supply among key players, which prompted manufacturers to lower their quotations to destock inventories. However, in December, there was a noticeable increase in prices due to increased demand for ibuprofen among consumers.

This analysis can be extended to include detailed ibuprofen price information for a comprehensive list of countries.

North America Ibuprofen Price

Q3 2024:

In Q3 2024, the North American ibuprofen market witnessed a marked increase in prices due to several contributing factors. A substantial rise in international demand, compounded by interruptions in supply networks, including logistical hurdles and plant closures, was a major contributor to the price escalation. Geopolitical pressures and increasing manufacturing expenses added further complexity to the pricing landscape, impacting ibuprofen availability. Overall, prices in the third quarter reflected an optimistic market sentiment, signaling strong industry performance and continued growth potential.

Q2 2024:

During the second quarter of 2024, ibuprofen prices in North America witnessed a notable increase owing to various circumstances. Ongoing interruptions in international supply networks, such as shipping delays, lack of containers, and global pressures, had a significant impact on the industry. Rising costs of energy and input material added to production expenses, contributing to the ascending pricing trend. Q2 also faced supply limitations due to maintenance activities and technical issues at major manufacturing facilities, tightening supply and driving prices higher.

Q4 2023:

In North America, the ibuprofen market underwent various challenges that affected the dynamics and price trends. Initially, the price declined because of global economic uncertainties, surplus availability of ibuprofen, and limited international demand. However, in December, the prices surge significantly because of increased freight charges, shortages of containers, and persistent congestion at the Panama Canal.

Specific ibuprofen historical data within the United States and Canada can also be provided.

Middle East and Africa Ibuprofen Price

The report explores the ibuprofen pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on ibuprofen prices for countries can also be provided.

Asia Pacific Ibuprofen Price

Q3 2024:

Throughout the third quarter of 2024, ibuprofen prices in Asia Pacific rose significantly due to numerous contributing factors. Supply challenges were primarily driven by interrupted operations, compounded by increased international requirements for exports from China. Seasonal closures of production facilities for maintenance added to supply constraints, tightening availability and driving prices higher. Furthermore, plant closures in various areas intensified these supply issues, emphasizing the sensitive supply-demand balance that shapes the pricing environment in Asia Pacific.

Q2 2024:

During the second quarter of 2024, ibuprofen prices in Asia Pacific witnessed a marked upward trend due to numerous contributing circumstances. Strong requirements from local and foreign markets drove prices higher, propelling distributors to revise strategies. Geopolitical pressures and operational challenges worsened inventory limitations, while fluctuations in currency raised manufacturing expenses. Additionally, planned facility closures for servicing and repairs further strained supplies, contributing to the upward pricing trajectory.

Q4 2023:

The Asia Pacific region experienced notable fluctuations in ibuprofen prices during the Q4 of 2023. The initial months of Q4 saw a decline in prices because of low to moderate demand and the availability of ample product supply. By December, the prices for ibuprofen rebounded due to an upswing in demand outlook.

This ibuprofen price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Ibuprofen Price

The analysis of ibuprofen prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Ibuprofen Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Ibuprofen Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2024 Edition,” offers an in-depth analysis of ibuprofen pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of ibuprofen at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of ibuprofen price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing ibuprofen price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Ibuprofen Market Analysis

The global ibuprofen market size reached US$ 93.1 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 117.3 Million, at a projected CAGR of 2.60% during 2023-2032.

• The heightened prevalence of chronic pain across the globe is bolstering the market share. Ibuprofen is a non-prescription pain relief solution that helps in alleviating arthritis, migraine headaches, and neuropathic pain. According to the World Health Organization (WHO), chronic diseases are on the rise globally, including those that cause severe pain. These diseases account for 41 million deaths, which is equivalent to 74% of all deaths worldwide. Also, according to the Centers for Disease Control and Prevention (CDC), the prevalence of chronic pain the US adults ranged from 20.5% to 21.8% between 2019 and 2021.
• The rising geriatric population has a profound impact on the expansion of the ibuprofen market. Geriatric individuals are affected by pain-causing conditions like osteoporosis, arthritis, and other musculoskeletal disorders. These conditions require effective pain management solutions like ibuprofen. According to recent findings, the proportion of the world’s population over 60 years will almost double from 12% to 22% between 2015 and 2050. Also, by 2050, 80% of the geriatric population will be present in low- and middle-income countries.
• Additionally, shifting consumer preferences towards self-medication and over-the-counter (OTC) drugs due to the desire for immediate relief, convenience, and perceived safety of OTC drugs. In this context, ibuprofen is considered a highly popular and trusted OTC pain reliever that provides relief from dental pain, headaches, minor injuries, and menstrual cramps. The latest findings show that 81% of adults prefer OTC medicines as a first response to minor ailments. In the US, a consumer makes around 26 trips/year to purchase OTC products. Also, there are more than 750000 retail outlets in the US that sell OTC products.
• The increasing healthcare spending around the world is an important factor in strengthening the market share. Countries are spending more on healthcare infrastructure to improve the availability and accessibility of medical treatment, including pain management solutions. For instance, in the European Union (EU), the general government spending on health amounted to €1221 billion or 7.7 % of GDP in 2022. Also, in the US, the healthcare spending grew by 4.1 percent, reaching $4.5 trillion or $13493/person.

Ibuprofen News

The report covers the latest developments, updates, and trends impacting the global ibuprofen market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in ibuprofen production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the ibuprofen price trend.

Latest developments in the ibuprofen industry:

• In August 2021, Alkem Laboratories announced the launch of ibuprofen and famotidine tablets in the US market.
• In November 2022, Salara Active Pharma bagged European certification for two manufacturing facilities for ibuprofen active pharmaceutical ingredients (API) in India.

Product Description

Ibuprofen (C13H18O2), also known as Motrin, refers to a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid. It also functions as a radical scavenger, geroprotector, cyclooxygenase 2 inhibitor, and non-narcotic analgesic. Colorless and crystalline, ibuprofen dissolves well in water, alcohol, and other organic solvents. Its melting point is 75-77.5 ºC, its boiling point is 157ºC, and its molecular weight is 206.28 g/mol.

Isobutylbenzene and acetic anhydride are raw materials used in the synthesis of ibuprofen. These raw materials go through the Friedel-Crafts acylation, carbonyl reduction, chloride substitution, and Grignard reaction processes.

It is used to control and treat osteoarthritis, rheumatoid disorders, inflammatory diseases, mild pain, dysmenorrhea, fever, headache, tooth pain, cramping during menstruation, muscle pains, and colds. Ibuprofen is a reasonably priced, very effective medication that helps patients live better, heal more quickly, regulate body temperature, and lessen discomfort.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of ibuprofen pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting ibuprofen price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ibuprofen price charts ensure our clients remain at the forefront of the industry.